Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1438943/000149315218014894/form8-k.htm
October 2021
September 2021
August 2021
August 2021
August 2021
June 2021
June 2021
March 2021
September 2020
May 2020
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1438943/000149315218014894/form8-k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Vitality Biopharma, Inc..
Vitality Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Vitality Biopharma, Inc. provided additional information to their SEC Filing as exhibits
Ticker: VBIOEvents:
CIK: 1438943
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-014894
Submitted to the SEC: Fri Oct 26 2018 4:42:38 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Monday, October 22, 2018
Industry: Commercial Physical And Biological Research